Treatment of multiple sclerosis with interferon beta-1b

被引：3
|
作者：
AbdulAhad, A
Shah, S
Galazka, A
机构：
来源：
NEUROLOGY | 1997年 / 49卷 / 02期
关键词：
D O I：
10.1212/WNL.49.2.641
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：641 / 641
页数：1
相关论文
共 50 条
  • [41] Neutralising antibodies in patients with multiple sclerosis treated with interferon beta-1b
    Río, J
    Barberà, N
    Tintoré, M
    Brieva, L
    Montalbán, X
    MEDICINA CLINICA, 2000, 114 (05): : 169 - 170
  • [42] INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL
    DUQUETTE, P
    DESPAULT, L
    KNOBLER, RL
    LUBLIN, FD
    KELLEY, L
    FRANCIS, GS
    FREEDMAN, M
    LAPIERRE, Y
    GREENSTEIN, JI
    MISHRA, B
    DELILLIO, N
    WHITAKER, J
    LAYTON, B
    SIBLEY, WA
    LAGUNA, J
    KRIKAWA, J
    PATY, DW
    OGER, JJ
    KASTRUKOFF, LF
    MORRISON, W
    NELSON, J
    GOODIN, D
    MASSA, SM
    GUTTERIDGE, E
    ARNASON, BGW
    NORONHA, A
    REDER, AT
    MARTIA, R
    EBERS, GC
    RICE, GPA
    LESAUX, J
    JOHNSON, KP
    PANITCH, HS
    BEVER, CT
    CONWAY, K
    LI, DKB
    TANTON, EL
    ZHAO, GJ
    FLAK, B
    RIDDEHOUGH, A
    COVER, K
    RHODES, B
    COOK, A
    SMITH, K
    COSTLEY, L
    RENNEBERG, S
    SHAW, T
    GENTON, M
    VANDENNOORT, S
    WEINSHENKER, B
    NEUROLOGY, 1995, 45 (07) : 1277 - 1285
  • [43] COMPARISON OF MEDICATION ADHERENCE TO INTERFERON BETA-1B AND INTERFERON BETA-1A SUBCUTANEOUS IN MULTIPLE SCLEROSIS PATIENTS
    Meletiche, D. M.
    Kozma, C.
    Dickson, M.
    VALUE IN HEALTH, 2009, 12 (03) : A194 - A194
  • [44] Vitamin D as a predictor of multiple sclerosis activity and progression in patients with multiple sclerosis on interferon beta-1b
    Ascherio, A.
    Fitzgerald, K.
    Munger, K.
    Kochert, K.
    Arnason, B.
    Cook, S.
    Comi, G.
    Filippi, M.
    Goodin, D.
    Hartung, H-P
    Jeffery, D.
    O'Connor, P.
    Suarez, G.
    Sandbrink, R.
    Kappos, L.
    Pohl, C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 47 - 47
  • [45] SWABIMS-SWiss atorvastatin and interferon beta-1b trial in multiple sclerosis
    Kamm, C
    Mattle, H
    Greeve, L
    Tettenborn, B
    Kappos, L
    Goebels, N
    MULTIPLE SCLEROSIS, 2005, 11 : S156 - S156
  • [46] Clinical pharmacology of interferon beta-1b and its potential role in multiple sclerosis
    Reder, AT
    CLINICAL IMMUNOTHERAPEUTICS, 1996, 5 : 31 - 40
  • [47] Psoriasis Associated with Interferon Beta-1b in a Multiple Sclerosis Patient with Positive Rechallenge
    Daldoul, M.
    Kaabi, W.
    Belgacem, M. B.
    Mahjoubi, Y.
    Daghfous, R.
    Aidli, S. E.
    DRUG SAFETY, 2022, 45 (10) : 1160 - 1160
  • [48] Interferon beta-1b in multiple sclerosis - A seminar-in-print - Questions and answers
    Thompson, AJ
    Hohlfeld, R
    Tyring, SK
    Reder, AT
    Sibley, WA
    Li, DKB
    CLINICAL IMMUNOTHERAPEUTICS, 1996, 5 : 55 - 58
  • [49] Meningioma growth and interferon beta-1b treated multiple sclerosis: coincidence or relationship?
    A. Drevelegas
    E. Xinou
    D. Karacostas
    D. Parissis
    G. Karkavelas
    I. Milonas
    Neuroradiology, 2005, 47 : 516 - 519
  • [50] Long-term experience with interferon beta-1b (Betaferon®) in multiple sclerosis
    Arnason, BGW
    JOURNAL OF NEUROLOGY, 2005, 252 (Suppl 3) : 28 - 33
12345